INFU

INFUSYSTEM HLDGS INC

INFU·45685K102·US·Common Stock·Healthcare - Medical Devices-13D/G

INFU (INFUSYSTEM HLDGS INC) is held by 53 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($7.9M), First Eagle Investment Management, LLC ($6.7M), BlackRock, Inc. ($5.7M). Net institutional sentiment: Mixed.

53
Holders
Avg rating(11 Elite)
$71.1M
Total Value
59% (60)
Fund Consensus
34 buying - 24 selling
INFUSmart Money Verdict
View all
Held by 53 funds
11 elite
Who's Trading
InsiderLCLachance CarrieBuy $18KMay 8, 2026
InsiderSGSteele Barry GBuy $61KMay 8, 2026
InsiderGAGENDRON PAUL ANDREWBuy $44KMay 8, 2026
InsiderSGSteele Barry GBuy $19KMar 2, 2026
ActivistMAMinerva Advisors LLC5.3%Feb 17, 2026
ActivistAIAWM Investment Company, Inc.2.8%Nov 13, 2025
InsiderSSShuda ScottSell $56KAug 22, 2025
ActivistThe Vanguard GroupThe Vanguard Group4.6%Jul 29, 2025
ActivistBlackRock, Inc.BlackRock, Inc.1.9%Jul 17, 2025
InsiderEDEichenbaum Kenneth D.Buy $10KMay 28, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
860,263$7.9M0.0%+5.45%
38
Decreased
721,371(-4.0%)$6.7M0.0%+12.47%
0
Increased
616,586(+1.1%)$5.7M0.0%+24.33%
27
Increased
594,288(+6.0%)$5.5M0.0%+29.32%
29
Decreased
566,809(-3.5%)$5.2M0.0%+7.42%
0
Increased
473,021(+34.3%)$4.4M0.0%+14.15%
35
Decreased
368,712(-12.0%)$3.4M0.0%+6.00%
0
Increased
354,559(+23.9%)$3.3M0.0%+32.34%
32
Increased
265,209(+84.5%)$2.4M0.0%+11.10%
41
Decreased
234,331(-23.4%)$2.2M0.0%+5.74%
0
Increased
218,445(+0.1%)$2M0.0%-5.90%
26
Increased
185,411(+165.3%)$1.7M0.0%+11.11%
41
Increased
169,954(+143.8%)$1.6M0.0%+22.28%
41
Decreased
148,485(-1.1%)$1.4M0.0%+11.36%
0
Decreased
130,058(-41.0%)$1.2M0.0%-0.99%
0
Decreased
127,870(-1.2%)$1.2M0.0%+67.96%
0
Decreased
127,307(-19.5%)$1.2M0.0%+30.77%
0
New
121,988$1.1M0.0%+5.45%
35
Increased
112,106(+110.7%)$1M0.0%0.00%
40
Increased
110,598(+21.2%)$1M0.0%+4.91%
30

Showing 1-20 of 60

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used